Exploring the metabolic-immune score in advanced NSCLC treated with immunotherapy

Abstract Identifying reliable prognostic markers in patients with advanced non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) is critical for clinical decision-making. This study introduces the Metabolic and Immune Score (MIS), a novel scoring system combining metabo...

Full description

Saved in:
Bibliographic Details
Main Authors: Beliz Bahar Karaoğlan, Ecenur Dursun, İrem Mesci, Mine Soylu Araz, Elif Berna Köksoy
Format: Article
Language:English
Published: Nature Portfolio 2025-08-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-16788-7
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items